382 related articles for article (PubMed ID: 31571367)
1. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
2. Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study.
Anbar TS; Westerhof W; Abdel-Rahman AT; Ewis AA; El-Khayyat MA
Photodermatol Photoimmunol Photomed; 2008 Dec; 24(6):322-9. PubMed ID: 19000191
[TBL] [Abstract][Full Text] [Related]
3. Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study.
Doghaim NN; Gheida SF; El-Tatawy RA; Mohammed Ali DA
J Cosmet Dermatol; 2019 Feb; 18(1):142-149. PubMed ID: 29707867
[TBL] [Abstract][Full Text] [Related]
4. Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo.
Yan R; Yuan J; Chen H; Li YH; Wu Y; Gao XH; Chen HD
Lasers Med Sci; 2017 Sep; 32(7):1571-1577. PubMed ID: 28710660
[TBL] [Abstract][Full Text] [Related]
5. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
6. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
7. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
Eşme P; Gür Aksoy G; Elçin G
Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
Abdelghani R; Ahmed NA; Darwish HM
J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
[TBL] [Abstract][Full Text] [Related]
10. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of using fractional CO
Ghasemloo S; Gauthier Y; Ghalamkarpour F
J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
[No Abstract] [Full Text] [Related]
12. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
Shin J; Lee JS; Hann SK; Oh SH
Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
Asawanonda P; Klahan SO
Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy for resistant vitiligo lesions: NB-UVB, microneedling, and topical latanoprost, showed no enhanced efficacy compared to topical latanoprost and NB-UVB.
Stanimirovic A; Kovacevic M; Korobko I; Šitum M; Lotti T
Dermatol Ther; 2016 Sep; 29(5):312-316. PubMed ID: 27356486
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
[No Abstract] [Full Text] [Related]
16. Comparison of NB-UVB combination therapy regimens for vitiligo: A systematic review and network meta-analysis.
Zhu B; Liu C; Zhang L; Wang J; Chen M; Wei Y
J Cosmet Dermatol; 2023 Mar; 22(3):1083-1098. PubMed ID: 36456176
[TBL] [Abstract][Full Text] [Related]
17. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
18. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.
Bayoumi W; Fontas E; Sillard L; Le Duff F; Ortonne JP; Bahadoran P; Lacour JP; Passeron T
Br J Dermatol; 2012 Jan; 166(1):208-11. PubMed ID: 21824124
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
Khullar G; Kanwar AJ; Singh S; Parsad D
J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
[TBL] [Abstract][Full Text] [Related]
20. The effect of platelet-rich plasma on the outcome of short-term narrowband-ultraviolet B phototherapy in the treatment of vitiligo: a pilot study.
Ibrahim ZA; El-Ashmawy AA; El-Tatawy RA; Sallam FA
J Cosmet Dermatol; 2016 Jun; 15(2):108-16. PubMed ID: 26695436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
